🔎 After looking at rebates, let’s turn to another way prices get adjusted in the drug supply chain: discounts.
➡️ Instead of money paid back later, discounts lower the price of a drug up front — usually negotiated by PBMs with manufacturers.
#HealthPolicy #DrugSupplyChain #CHBRP #DrugDiscounts
🔎 After looking at rebates, let’s turn to another way prices get adjusted in the drug supply chain: discounts.
➡️ Instead of money paid back later, discounts lower the price of a drug up front — usually negotiated by PBMs with manufacturers.
#HealthPolicy #DrugSupplyChain #CHBRP #DrugDiscounts
🆕 Continuing our series on prescription drugs: let’s spotlight a major but often hidden piece of the puzzle — drug rebates.
💊 How do rebates work? Who benefits from them? Let’s break it down.
#HealthPolicy #DrugSupplyChain #PBMs #CHBRP #DrugRebates
🆕 Continuing our series on prescription drugs: let’s spotlight another key player in the drug supply chain — pharmacy benefit managers (PBMs).
💊 What exactly do PBMs do? How do they shape access and affordability? Let’s break it down.
#HealthPolicy #DrugSupplyChain #PBMs #CHBRP
🆕 Continuing our series on prescription drugs: let’s spotlight another player in the drug supply chain: wholesalers.
➡️ These companies don’t make or prescribe drugs, but they’re crucial for getting medications from manufacturers to your local pharmacy.
#DrugSupplyChain #Wholesalers #CHBRP
New research shows Canada supplies up to $3B in pharmaceuticals to the U.S. A proposed 25% tariff could add $750M in costs and strain supply chains. Published @jama.com, lead author Assistant Prof. Mina Tadrous weighs in.
#HealthPolicy | #DrugSupplyChain | #CanadaUSTrade | @uoft.bsky.social
Longitudinal cross-sectional study of drug supply chain issues 2017-2021, Canada vs US. Lower risk of drug shortage both before and after COVID19 in Canada and issues were 40% less likely to result in meaningful drug shortages #medsky #oncsky #drugsupplychain pubmed.ncbi.nlm.nih.gov/39480469/
